Chemotherapy: Irinotecan or etoposide as front-line therapy for SCLC?

MeSH terms

• ATP Binding Cassette Transporter, Subfamily B
• ATP Binding Cassette Transporter, Subfamily B, Member 1 / genetics
• Antineoplastic Agents / therapeutic use
• Antineoplastic Agents, Phytogenic / therapeutic use
• Biological Transport / drug effects
• Camptothecin / analogs & derivatives*
• Camptothecin / metabolism
• Camptothecin / pharmacokinetics
• Camptothecin / therapeutic use
• Carboplatin / pharmacokinetics
• Carboplatin / therapeutic use
• Cisplatin / therapeutic use
• Clinical Trials, Phase III as Topic
• Diarrhea / chemically induced
• Drug Therapy / methods*
• Drug Therapy, Combination
• Enzyme Inhibitors / therapeutic use
• Ethnicity / genetics
• Etoposide / therapeutic use*
• Female
• Follow-Up Studies
• Glucuronosyltransferase / genetics
• Humans
• Irinotecan
• Lung Neoplasms / drug therapy*
• Lung Neoplasms / mortality
• Lung Neoplasms / pathology
• Male
• Neutropenia / chemically induced
• Polymorphism, Genetic
• Randomized Controlled Trials as Topic
• Small Cell Lung Carcinoma / drug therapy*
• Small Cell Lung Carcinoma / mortality
• Small Cell Lung Carcinoma / pathology
• Survival Analysis
• Therapeutic Equivalency
• Time Factors
• Treatment Outcome